Implantable 'Cell Pouch' could free diabetics from insulin shots?
NCT ID NCT03513939
First seen Feb 28, 2026 · Last updated May 14, 2026 · Updated 8 times
Summary
This study tests a device called the Cell Pouch, which is implanted in the abdomen to house insulin-producing cells for people with Type 1 Diabetes who have dangerous low blood sugar episodes. The goal is to see if the device is safe and can help the cells survive long-term, potentially reducing the need for insulin injections. The trial involves 17 participants and is in early-to-mid stages.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.